Skip to content
Medical Health Aged Care

QNMU welcomes new nurse-led Queensland healthcare clinics

Queensland Nurses and Midwives' Union (QNMU) < 1 mins read

The Queensland Nurses and Midwives’ Union (QNMU) has welcomed the Miles Government’s announcement of four new nurse-led healthcare clinics across Queensland.

 

The clinics will operate for extended hours (8am to 10pm) seven days a week, with highly-qualified Nurse Practitioners (NPs) and nurses providing Queenslanders with access to free healthcare, when and where they need it in the community.

 

The Minister for Health, Mental Health and Ambulance Service and Minister for Women Shannon Fentiman, said the clinics will focus on women’s healthcare, providing treatment for non-life threatening injuries and illnesses.

 

This is a win for the QNMU which has long-campaigned for the establishment of nurse-led models of care in Queensland, pointing to the success of walk-in clinics in the ACT and Tasmania.

 

“We commend the Miles Government for this increased investment in nurses and innovative models of nurse-led primary care,” QNMU Secretary Sarah Beaman said today.

 

“Nurse-led practice models in the ACT and Tasmania have been very successful in providing people with treatment and preventative healthcare, helping alleviate wait times in EDs, as hospitals struggle with workforce shortages and increased demands for health services.

 

“In a cost-of-living crisis, free healthcare has never been more important, and some of our QNMU members have expressed concerns that our EDs are becoming a ‘one-stop shop’ for all kinds of health conditions.

 

“The QNMU applauds this increased investment in nurses and in innovative models of nurse-led primary care which will allow more Queenslanders to receive quality, safe healthcare in the community, without the need to go to a ED or a doctor.”

 


Contact details:

0411 254390

More from this category

  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:31
Dementia Australia

New report reinforces dementia as chronic disease of 21st century

Updates to the Dementia in Australia report, released today by the Australian Institute of Health and Welfare (AIHW), reinforce that dementia is an urgent public health issue. Dementia is the second leading cause of death in Australia, the leading cause of death of women, the second leading cause of disease burden overall, and the leading cause of burden for people aged 65 and over. Dementia Australia CEO Professor Tanya Buchanan saidthe report highlights the enormity and impact of dementia in Australia as the chronic disease of the 21st century. “Despite the growing number of Australians diagnosed with dementia – there…

  • Medical Health Aged Care, Science
  • 13/09/2024
  • 11:08
La Trobe University

Centre to play key role in global AI medical research

Artificial intelligence promises to unlock new cures for cancer and other diseases by revolutionising the speed, cost and availability of personally designed drugs and enabling these to be tested on “digital twins" before being given to patients. AI will enable broad-spectrum like chemotherapy to be replaced by these more personalised, better targeted treatments. Scientists at La Trobe University's new Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI), launched today, will also apply AI techniques to mRNA therapy development to enable faster design of more precise and effective treatments. Vice-Chancellor Professor Theo Farrell said ACAMI would sit within La Trobe’s…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.